Wee1-like protein kinase
Homo sapiens
当前结构中的状态
| Assembly | 聚集状态 | 构建体 | 突变与修饰 | 配体、离子与共同组分 | 实验方法与环境 | 结构质量 |
|---|---|---|---|---|---|---|
| 1 | 蛋白单体 单体 蛋白 × 1 PDB 声明:monomeric(1) 与蛋白拷贝数一致 | 链 A; UniProt 291–575 | 片段:UNP RESIDUES 291-575 | P48 N,1,4,4-TETRAMETHYL-8-{[4-(4-METHYLPIPERAZIN-1-YL)PHENYL]AMINO}-4,5-DIHYDRO-1H-PYRAZOLO[4,3-H]QUINAZOLINE-3-CARBOXAMIDE × 1 EDO 1,2-ETHANEDIOL × 1 | X-RAY DIFFRACTION X-ray结晶条件:VAPOR DIFFUSION, HANGING DROP;pH 6.9;291 K;5.0 MG/ML WEE1, 25 mM Na/K phosphate, 1 mM DTT, 0.05 M ammonium sulfate, 0.05 M Bis-tris (pH 5.5), 7.5 % PEG 3350, 1 mM PHA-848125 | 分辨率 2.00 Å R-free 0.265 |
数据库中的同蛋白其他状态
以下每一行都是同一 UniProt 蛋白在另一个 PDB 条目中的 biological assembly, “相对当前条目”直接指出证据层面的不同;没有差异标签表示当前已读取字段一致。
| 其他 PDB | 相对当前条目 5VC6 | Assembly / 聚集状态 | 构建体 | 突变与修饰 | 配体、离子与非聚合物 | 实验方法与环境 | 结构质量 |
|---|---|---|---|---|---|---|---|
| 1X8B Structure of human Wee1A kinase: kinase domain complexed with inhibitor PD0407824 提交 2004-08-17 | 构建体不同 配体/离子不同 实验环境不同 结构质量不同 | Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric |
链 A
291–575(285 aa)
片段:kinase domain
|
未记录 | MG MAGNESIUM ION × 2 824 9-HYDROXY-4-PHENYLPYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE × 1 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;HEPES, sodium chloride, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
分辨率 1.81 Å R-free 0.237 |
| 2IN6 Wee1 kinase complex with inhibitor PD311839 提交 2006-10-05 | 构建体不同 配体/离子不同 实验环境不同 结构质量不同 | Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric |
链 A
291–575(285 aa)
片段:kinase domain
|
未记录 | 839 3-(9-HYDROXY-1,3-DIOXO-4-PHENYL-2,3-DIHYDROPYRROLO[3,4-C]CARBAZOL-6(1H)-YL)PROPANOIC ACID × 1 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;HEPES, sodium chloride, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
分辨率 1.90 Å R-free 0.299 |
| 2IO6 Wee1 kinase complexed with inhibitor PD330961 提交 2006-10-10 | 构建体不同 配体/离子不同 实验环境不同 结构质量不同 | Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric |
链 A
291–575(285 aa)
片段:kinase domain
|
未记录 | 330 9-HYDROXY-6-(3-HYDROXYPROPYL)-4-(2-METHOXYPHENYL)PYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE × 1 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;HEPES, sodium chloride, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
分辨率 2.20 Å R-free 0.273 |
| 2Z2W Human Wee1 kinase complexed with inhibitor PF0335770 提交 2007-05-29 | 构建体不同 突变/修饰不同 聚集状态不同 配体/离子不同 实验环境不同 结构质量不同 | Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric |
链 A
291–575(285 aa)
片段:kinase domain
|
非标准单体:是(mmCIF未提供具体位点) | CL CHLORIDE ION × 2 770 N-[4-(2-CHLOROPHENYL)-1,3-DIOXO-1,2,3,6-TETRAHYDROPYRROLO[3,4-C]CARBAZOL-9-YL]FORMAMIDE × 2 GOL GLYCEROL × 2 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;NaCL, HEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
分辨率 2.22 Å R-free 0.271 |
| 2Z2W Human Wee1 kinase complexed with inhibitor PF0335770 提交 2007-05-29 | 构建体不同 突变/修饰不同 配体/离子不同 实验环境不同 结构质量不同 | Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric |
链 A
291–575(285 aa)
片段:kinase domain
|
非标准单体:是(mmCIF未提供具体位点) | CL CHLORIDE ION × 1 770 N-[4-(2-CHLOROPHENYL)-1,3-DIOXO-1,2,3,6-TETRAHYDROPYRROLO[3,4-C]CARBAZOL-9-YL]FORMAMIDE × 1 GOL GLYCEROL × 1 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;NaCL, HEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
分辨率 2.22 Å R-free 0.271 |
| 3BI6 Wee1 kinase complex with inhibitor PD352396 提交 2007-11-29 | 构建体不同 配体/离子不同 实验环境不同 结构质量不同 | Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric |
链 A
291–575(285 aa)
片段:kinase domain
|
未记录 | CL CHLORIDE ION × 1 396 4-(2-chlorophenyl)-9-hydroxy-6-methyl-1,3-dioxo-N-(2-pyrrolidin-1-ylethyl)pyrrolo[3,4-g]carbazole-8-carboxamide × 1 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;HEPES, NaCl, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
分辨率 2.20 Å R-free 0.251 |
| 3BIZ Wee1 kinase complex with inhibitor PD331618 提交 2007-12-02 | 构建体不同 配体/离子不同 实验环境不同 结构质量不同 | Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric |
链 A
291–575(285 aa)
片段:kinase domain
|
未记录 | CL CHLORIDE ION × 1 61E 4-(2-chlorophenyl)-8-[3-(dimethylamino)propoxy]-9-hydroxy-6-methylpyrrolo[3,4-c]carbazole-1,3(2H,6H)-dione × 1 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;HEPES, NaCl, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
分辨率 2.20 Å R-free 0.247 |
| 3CQE Wee1 kinase complex with inhibitor PD074291 提交 2008-04-02 | 构建体不同 配体/离子不同 实验环境不同 结构质量不同 | Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric |
链 A
291–575(285 aa)
片段:kinase domain
|
未记录 | CL CHLORIDE ION × 1 P91 8-bromo-4-(2-chlorophenyl)-N-(2-hydroxyethyl)-6-methyl-1,3-dioxo-1,2,3,6-tetrahydropyrrolo[3,4-e]indole-7-carboxamide × 1 GOL GLYCEROL × 1 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 7.5;HEPES, sodium chloride, pH 7.5, VAPOR DIFFUSION, HANGING DROP
|
分辨率 2.50 Å R-free 0.268 |
| 3CR0 Wee1 kinase complex with inhibitor PD259_809 提交 2008-04-03 | 构建体不同 配体/离子不同 实验环境不同 结构质量不同 | Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric |
链 A
291–575(285 aa)
片段:kinase domain
|
未记录 | CL CHLORIDE ION × 1 809 4-(2-chlorophenyl)-8-(2-hydroxyethyl)-6-methylpyrrolo[3,4-e]indole-1,3(2H,6H)-dione × 1 GOL GLYCEROL × 1 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;HEPES, sodium chloride, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
分辨率 2.30 Å R-free 0.255 |
| 5V5Y CRYSTAL STRUCTURE OF HUMAN WEE1 KINASE DOMAIN IN COMPLEX WITH MK1775 提交 2017-03-15 | 配体/离子不同 实验环境不同 结构质量不同 | Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric |
链 A
291–575(285 aa)
片段:UNP RESIDUES 291-575
|
未记录 | 8X7 1-[6-(2-hydroxypropan-2-yl)pyridin-2-yl]-6-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-2-(prop-2-en-1-yl)-1,2-dihydro-3H-pyrazolo[3,4-d]pyrimidin-3-one × 1 DMS DIMETHYL SULFOXIDE × 2 EDO 1,2-ETHANEDIOL × 2 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 6.9;291 K;9.0 MG/ML WEE1, 25 mM Na/K phosphate, 1 mM DTT, 0.1 M ammonium sulfate, 0.05 M Bis-tris (pH 5.5), 12.5 % PEG 3350, 1 mM MK1775
|
分辨率 1.90 Å R-free 0.215 |
| 5VC3 CRYSTAL STRUCTURE OF HUMAN WEE1 KINASE DOMAIN IN COMPLEX WITH BOSUTINIB 提交 2017-03-30 | 配体/离子不同 实验环境不同 结构质量不同 | Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric |
链 A
291–575(285 aa)
片段:UNP RESIDUES 291-575
|
未记录 | DB8 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile × 1 EDO 1,2-ETHANEDIOL × 4 CL CHLORIDE ION × 1 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 6.9;291 K;5.0 MG/ML WEE1, 25 mM Na/K phosphate, 1 mM DTT, 0.05 M ammonium sulfate, 0.05 M Bis-tris (pH 5.5),7.5 % PEG 3350, 1 mM Bosutinib
|
分辨率 1.97 Å R-free 0.254 |
| 5VC4 Crystal structure of HUMAN WEE1 KINASE domain in complex with Bosutinib-isomer 提交 2017-03-30 | 突变/修饰不同 配体/离子不同 实验环境不同 结构质量不同 | Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric |
链 A
291–575(285 aa)
片段:UNP RESIDUES 291-575
|
突变:NONE | XZN 4-[(3,5-DICHLORO-4-METHOXYPHENYL)AMINO]-6-METHOXY-7-[3-(4-METHYLPIPERAZIN-1-YL)PROPOXY]QUINOLINE-3-CARBONITRILE × 1 PO4 PHOSPHATE ION × 1 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 6.9;291 K;5.0 MG/ML WEE1, 25 mM Na/K phosphate, 1 mM DTT, 0.05 M ammonium sulfate, 0.05 M Bis-tris (pH 5.5), 7.5 % PEG 3350, 1 mM Bosutinib-isomer
|
分辨率 2.10 Å R-free 0.241 |
| 5VC5 Crystal structure of human WEE1 kinase domain in complex with PD-166285 提交 2017-03-31 | 配体/离子不同 实验环境不同 结构质量不同 | Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric |
链 A
291–575(285 aa)
片段:UNP RESIDUES 291-575
|
未记录 | 96M 6-(2,6-dichlorophenyl)-2-({4-[2-(diethylamino)ethoxy]phenyl}amino)-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one × 1 EDO 1,2-ETHANEDIOL × 1 CL CHLORIDE ION × 2 PEG DI(HYDROXYETHYL)ETHER × 1 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 6.9;291 K;9.0 MG/ML WEE1, 25 mM Na/K phosphate, 1 mM DTT, 0.05 M ammonium sulfate, 0.05 M Bis-tris (pH 5.5), 7.5 % PEG 3350, 1 mM PD-166285
|
分辨率 1.93 Å R-free 0.217 |
| 5VD2 crystal structure of human WEE1 kinase domain in complex with PF-03814735 提交 2017-04-01 | 配体/离子不同 实验环境不同 结构质量不同 | Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric |
链 A
291–575(285 aa)
片段:UNP RESIDUES 291-575
|
未记录 | 34W N-{2-[(1S,4R)-6-{[4-(cyclobutylamino)-5-(trifluoromethyl)pyrimidin-2-yl]amino}-1,2,3,4-tetrahydro-1,4-epiminonaphthalen-9-yl]-2-oxoethyl}acetamide × 1 PO4 PHOSPHATE ION × 1 CL CHLORIDE ION × 2 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 6.9;291 K;9.0 MG/ML WEE1, 25 mM Na/K phosphate, 1 mM DTT, 0.05 M ammonium sulfate, 0.05 M Bis-tris (pH 5.5), 7.5 % PEG 3350, 1 mM PF-03814735
|
分辨率 2.05 Å R-free 0.256 |
| 5VD4 CRYSTAL STRUCTURE OF HUMAN WEE1 KINASE DOMAIN IN COMPLEX WITH RAC-IV-016, a MK1775 analougue 提交 2017-04-01 | 配体/离子不同 实验环境不同 结构质量不同 | Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric |
链 A
291–575(285 aa)
片段:UNP RESIDUES 291-575
|
未记录 | 99J 6-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-2-(prop-2-en-1-yl)-1-{6-[(1S)-2,2,2-trifluoro-1-hydroxyethyl]pyridin-2-yl}-1,2-dihydro-3H-pyrazolo[3,4-d]pyrimidin-3-one × 1 PO4 PHOSPHATE ION × 2 EDO 1,2-ETHANEDIOL × 3 CL CHLORIDE ION × 1 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 6.9;291 K;5.0 MG/ML WEE1, 25 mM Na/K phosphate, 1 mM DTT, 0.05 M ammonium sulfate, 0.05 M Bis-tris (pH 5.5), 7.5 % PEG 3350, 1 mM RAC-IV-016
|
分辨率 2.02 Å R-free 0.245 |
| 5VD5 CRYSTAL STRUCTURE OF HUMAN WEE1 KINASE DOMAIN IN COMPLEX WITH RAC-IV-050, a MK1775 analougue 提交 2017-04-01 | 配体/离子不同 实验环境不同 结构质量不同 | Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric |
链 A
291–575(285 aa)
片段:UNP RESIDUES 291-575
|
未记录 | 99M 1-[6-(2-hydroxypropan-2-yl)pyridin-2-yl]-6-{[4-(morpholin-4-yl)phenyl]amino}-2-(prop-2-en-1-yl)-1,2-dihydro-3H-pyrazolo [3,4-d]pyrimidin-3-one × 1 CL CHLORIDE ION × 1 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 6.9;291 K;5.0 MG/ML WEE1, 25 mM Na/K phosphate, 1 mM DTT, 0.05 M ammonium sulfate, 0.05 M Bis-tris (pH 5.5), 7.5 % PEG 3350, 1 mM RAC-IV-050
|
分辨率 2.05 Å R-free 0.234 |
| 5VD7 CRYSTAL STRUCTURE OF HUMAN WEE1 KINASE DOMAIN IN COMPLEX WITH RAC-IV-098, a MK1775 analogue 提交 2017-04-01 | 配体/离子不同 实验环境不同 结构质量不同 | Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric |
链 A
291–575(285 aa)
片段:UNP RESIDUES 291-575
|
未记录 | 99V 6-{[3-fluoro-4-(4-methylpiperazin-1-yl)phenyl]amino}-1-[6-(2-hydroxypropan-2-yl)pyridin-2-yl]-2-(prop-2-en-1-yl)-1,2-dihydro-3H-pyrazolo[3,4-d]pyrimidin-3-one × 1 CL CHLORIDE ION × 1 EDO 1,2-ETHANEDIOL × 1 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 6.9;291 K;5.0 MG/ML WEE1, 25 mM Na/K phosphate, 1 mM DTT, 0.05 M ammonium sulfate, 0.05 M Bis-tris (pH 5.5), 7.5 % PEG 3350, 1 mM RAC-IV-098
|
分辨率 2.08 Å R-free 0.248 |
| 5VD8 Crystal structure of human WEE1 kinase domain in complex with RAC-IV-099, a MK1775 analogue 提交 2017-04-01 | 配体/离子不同 实验环境不同 结构质量不同 | Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric |
链 A
291–575(285 aa)
片段:UNP RESIDUES 291-575
|
未记录 | 98M 6-{[3-chloro-4-(4-methylpiperazin-1-yl)phenyl]amino}-1-[6-(2-hydroxypropan-2-yl)pyridin-2-yl]-2-(prop-2-en-1-yl)-1,2-dihydro-3H-pyrazolo[3,4-d]pyrimidin-3-one × 1 CL CHLORIDE ION × 1 EDO 1,2-ETHANEDIOL × 2 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 6.9;291 K;5.0 MG/ML WEE1, 25 mM Na/K phosphate, 1 mM DTT, 0.05 M ammonium sulfate, 0.05 M Bis-tris (pH 5.5), 7.5 % PEG 3350, 1 mM RAC-IV-099
|
分辨率 1.85 Å R-free 0.247 |
| 5VD9 Crystal structure of human WEE1 kinase domain in complex with RAC-IV-097, a MK1775 analogue 提交 2017-04-01 | 配体/离子不同 实验环境不同 结构质量不同 | Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric |
链 A
291–575(285 aa)
片段:UNP RESIDUES 291-575
|
未记录 | 98G 1-{6-[(1R)-1-hydroxyethyl]pyridin-2-yl}-6-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-2-(prop-2-en-1-yl)-1,2-dihydro-3H-pyrazolo[3,4-d]pyrimidin-3-one × 1 CL CHLORIDE ION × 1 EDO 1,2-ETHANEDIOL × 1 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 6.9;291 K;5.0 MG/ML WEE1, 25 mM Na/K phosphate, 1 mM DTT, 0.05 M ammonium sulfate, 0.05 M Bis-tris (pH 5.5), 7.5 % PEG 3350, 1 mM RAC-IV-097
|
分辨率 1.87 Å R-free 0.253 |
| 5VDA Crystal structure of human WEE1 kinase domain in complex with RAC-IV-101, a MK1775 analogue 提交 2017-04-01 | 配体/离子不同 实验环境不同 结构质量不同 | Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric |
链 A
291–575(285 aa)
片段:UNP RESIDUES 291-575
|
未记录 | 98D 1-{6-[(1S)-1-hydroxyethyl]pyridin-2-yl}-6-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-2-(prop-2-en-1-yl)-1,2-dihydro-3H-pyrazolo[3,4-d]pyrimidin-3-one × 1 CL CHLORIDE ION × 1 EDO 1,2-ETHANEDIOL × 1 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 6.9;291 K;5.0 MG/ML WEE1, 25 mM Na/K phosphate, 1 mM DTT, 0.05 M ammonium sulfate, 0.05 M Bis-tris (pH 5.5), 7.5 % PEG 3350, 1 mM RAC-IV-101
|
分辨率 2.10 Å R-free 0.255 |
| 7N3U Crystal structure of human WEE1 kinase domain in complex with ZN-c3 提交 2021-06-02 | 构建体不同 配体/离子不同 实验环境不同 结构质量不同 | Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric |
链 A
291–575(285 aa)
|
未记录 | 05J 1-[(7R)-7-ethyl-7-hydroxy-6,7-dihydro-5H-cyclopenta[b]pyridin-2-yl]-6-[4-(4-methylpiperazin-1-yl)anilino]-2-(prop-2-en-1-yl)-1,2-dihydro-3H-pyrazolo[3,4-d]pyrimidin-3-one × 1 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 8;291.15 K;20% PEG 20K
|
分辨率 2.65 Å R-free 0.267 |
| 8BJU HUMAN WEE1 KINASE IN COMPLEX WITH INHIBITOR 1-[6-(1-Hydroxy-1-methyl-ethyl)-pyridin-2-yl]-2-(2-methoxy-phenyl)-6-[4-(4-methyl-piperazin-1-yl)-phenylamino]-1,2-dihydro-pyrazolo[3,4-d]pyrimidin-3-one 提交 2022-11-06 | 构建体不同 配体/离子不同 实验环境不同 结构质量不同 | Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric |
链 A
291–575(285 aa)
|
未记录 | QT9 2-(2-methoxyphenyl)-6-[[4-(4-methylpiperazin-1-yl)phenyl]amino]-1-[6-(2-oxidanylpropan-2-yl)pyridin-2-yl]pyrazolo[3,4-d]pyrimidin-3-one × 1 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 4.75;277 K;6.0 % w/v PEG6000, 0.10M MES pH 4.75
|
分辨率 1.53 Å R-free 0.263 |
| 8WDK The complex structure of Cul2-VCB-Protac-Wee1 提交 2023-09-15 | 构建体不同 聚集状态不同 配体/离子不同 实验方法不同 实验环境不同 结构质量不同 | Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 6 PDB 声明:hexameric |
链 W
291–575(285 aa)
|
未记录 | W6U (2S,4R)-1-[(2S)-3,3-dimethyl-2-[3-[4-[4-[4-[[3-oxidanylidene-1-[6-(2-oxidanylpropan-2-yl)pyridin-2-yl]-2-prop-2-enyl-pyrazolo[3,4-d]pyrimidin-6-yl]amino]phenyl]piperazin-1-yl]butoxy]propanoylamino]butanoyl]-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-4-oxidanyl-pyrrolidine-2-carboxamide × 1 |
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 8
cryo-EM玻璃化条件
冷冻剂 ETHANE
|
分辨率 3.64 Å |
| 9D0Q Crystal structure of human Wee1 kinase domain in complex with inhibitor 提交 2024-08-07 | 构建体不同 配体/离子不同 实验环境不同 结构质量不同 | Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric |
链 A
291–575(285 aa)
|
未记录 | A1A1S 1-[(6R)-6-(2,6-dichlorophenyl)-8-methyl-2-[4-(4-methylpiperazin-1-yl)anilino]-7,8-dihydropteridin-5(6H)-yl]ethan-1-one × 1 NA SODIUM ION × 1 CL CHLORIDE ION × 8 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;293 K;hepes, sodiium chloride, pH 7.5
|
分辨率 1.96 Å R-free 0.270 |
| 9D0Q Crystal structure of human Wee1 kinase domain in complex with inhibitor 提交 2024-08-07 | 构建体不同 配体/离子不同 实验环境不同 结构质量不同 | Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric |
链 B
291–575(285 aa)
|
未记录 | A1A1S 1-[(6R)-6-(2,6-dichlorophenyl)-8-methyl-2-[4-(4-methylpiperazin-1-yl)anilino]-7,8-dihydropteridin-5(6H)-yl]ethan-1-one × 1 NA SODIUM ION × 1 CL CHLORIDE ION × 9 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;293 K;hepes, sodiium chloride, pH 7.5
|
分辨率 1.96 Å R-free 0.270 |
| 9D0R Crystal structure of human Wee1 kinase domain in complex with inhibitor 提交 2024-08-07 | 构建体不同 配体/离子不同 实验环境不同 结构质量不同 | Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric |
链 A
291–575(285 aa)
|
未记录 | NA SODIUM ION × 1 CL CHLORIDE ION × 5 A1A1T 7-methyl-2-{[1-(1-methylpiperidin-4-yl)-1H-pyrazol-4-yl]amino}-6-[(1R)-1-(thiophen-2-yl)ethyl]-7H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile × 1 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;hepes, sodium chloride, pH 7.5
|
分辨率 2.34 Å R-free 0.256 |
| 9D0S Crystal structure of human Wee1 kinase domain in complex with inhibitor 提交 2024-08-07 | 构建体不同 配体/离子不同 实验环境不同 结构质量不同 | Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric |
链 A
291–575(285 aa)
|
未记录 | NA SODIUM ION × 1 CL CHLORIDE ION × 13 A1A1R (8P)-3-(2,6-dichlorophenyl)-1-methyl-8-[1-(1-methylpiperidin-4-yl)-1H-pyrazol-4-yl]-1,2,3,7-tetrahydro-4H-pyrrolo[3',2':5,6]pyrido[4,3-d]pyrimidin-4-one × 1 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;hepes, sodium chloride, pH 7.5
|
分辨率 1.64 Å R-free 0.222 |
| 9R55 Wee1-like kinase in complex wirh MIPS-54859 提交 2025-05-08 | 构建体不同 配体/离子不同 实验环境不同 结构质量不同 | Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric |
链 A
292–575(284 aa)
|
未记录 | A1JDB MIPS-54859 × 1 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;293.15 K;20% w/v PEG 8000, 0.2 M Magnesium acetate tetrahydrate, 0.1M Sodium cacodylate, pH 6.5
|
分辨率 2.67 Å R-free 0.264 |
| 9R55 Wee1-like kinase in complex wirh MIPS-54859 提交 2025-05-08 | 构建体不同 配体/离子不同 实验环境不同 结构质量不同 | Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric |
链 B
292–575(284 aa)
|
未记录 | A1JDB MIPS-54859 × 1 EDO 1,2-ETHANEDIOL × 1 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;293.15 K;20% w/v PEG 8000, 0.2 M Magnesium acetate tetrahydrate, 0.1M Sodium cacodylate, pH 6.5
|
分辨率 2.67 Å R-free 0.264 |
| 9R56 Wee1-like kinase in complex wirh MIPS-54861 提交 2025-05-08 | 构建体不同 配体/离子不同 实验环境不同 结构质量不同 | Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric |
链 A
292–575(284 aa)
|
未记录 | EDO 1,2-ETHANEDIOL × 2 A1JDC MIPS-54861 × 1 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;293 K;20% PEG6000, 10% ethylene glycol, 0.1M MES pH 6.0, 0.2M ammonium chloride
|
分辨率 3.01 Å R-free 0.292 |
| 9R56 Wee1-like kinase in complex wirh MIPS-54861 提交 2025-05-08 | 构建体不同 配体/离子不同 实验环境不同 结构质量不同 | Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric |
链 B
292–575(284 aa)
|
未记录 | A1JDC MIPS-54861 × 1 GOL GLYCEROL × 1 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;293 K;20% PEG6000, 10% ethylene glycol, 0.1M MES pH 6.0, 0.2M ammonium chloride
|
分辨率 3.01 Å R-free 0.292 |
| 9TG7 Crystal structure of beta-TrCP bound by monophosphorylated WEE1 degron peptide 提交 2025-11-28 | 构建体不同 突变/修饰不同 聚集状态不同 配体/离子不同 实验环境不同 结构质量不同 | Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric |
链 B
49–60(12 aa)
|
非标准单体:是(mmCIF未提供具体位点) | 未记录非水小分子 |
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;297 K;20% PEG10K, 0.1 M
Na-Hepes pH 7.5
|
分辨率 1.68 Å R-free 0.252 |
共 28 个其他 PDB 条目、32 个 assembly。 打开独立比较页并筛选聚集状态
查看构建体与数据证据
| UniProt名称 | WEE1_HUMAN |
| Isoform | — |
| PDB实体 | 1 |
| 链与序列区间 | 作者链 A; PDB构建体 5–289; UniProt 291–575 |